[1] Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev 2011;24:755–91.
[2] Naumiuk L, Baraniak A, Gniadkowski M, Krawczyk B, Rybak B, Sadowy E, et al. Molecular epidemiology of Serratia marcescens in two hospitals in Gdan´ sk, Poland, over a 5-year period. J Clin Microbiol 2004;42:3108–16.
[3] Cheng KC, Chuang YC, Wu LT, Huang GC, Yu WL. Clinical experiences of the infections caused by extended-spectrum β-lactamase-producing Serratia marcescens at a medical center in Taiwan. Jpn J Infect Dis 2006;59:147–52.
[4] Markovska RD, Stoeva TJ, Bojkova KD, Mitov IG. Epidemiology and molecu- lar characterization of extended-spectrum β-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital. Microb Drug Resist 2014;20:131–7.
[5] Yamasaki K, Komatsu M, Yamashita T, Shimakawa K, Ura T, Nishio H, et al. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 met-allo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki Region of Japan. J Antimicrob Chemother 2003;51:631–8.
[6] Ivanova D, Markovska R, Hadjieva N, Schneider I, Mitov I, Bauernfeind A. Extended-spectrum β-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital. J Hosp Infect 2008;70:60–5.
[7] Batah R, Loucif L, Olaitan AO, Boutefnouchet N, Allag H, Rolain JM. Outbreak of Serratia marcescens coproducing ArmA and CTX-M-15 mediated high levels of resistance to aminoglycoside and extended-spectrum β-lactamases. Algeria. Microb Drug Resist 2015;21:470–6.
[8] Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M, et al. Risk factors for extended-spectrum β-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp In- fect 2007;67:135–41.
[9] Espinosa de los Monteros LE, Silva-Sanchez J, Jiménez LV, Rojas T, Garza-Ramos U, Valverde V. Outbreak of infection by extended-spectrum β-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital. J Chemother 2008;20:586–92.
[10] Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Micro- biol Rev 1995;8:557–84.
[11] Claeys G, De Baere T, Vaneechoutte M, Verschraegen G. Caz-hi, an extend- ed-spectrum TEM β-lactamase (TEM-61), is derived from Caz-lo (TEM-11) by in vivo-selection. Antimicrob Agents Chemother 1998;42:3328–9.
[12] Vuye A, Verschraegen G, Claeys G. Plasmid-mediated β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother 1989;33:757–61.
[13] Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 28th ed. Wayne, PA: CLSI; 2018. CLSI sup- plement M100.
[14] Hayashi W, Ohsaki Y, Taniguchi Y, Koide S, Kawamura K, Suzuki M, et al. High prevalence of blaCTX-M-14 among genetically diverse Escherichia coli recov- ered from retail raw chicken meat portions in Japan. Int J Food Microbiol 2018;284:98–104.
[15] Hayashi W, Tanaka H, Taniguchi Y, Iimura M, Soga E, Kubo R, et al. Acquisition of mcr-1 and cocarriage of virulence genes in avian pathogenic Escherichia coli isolates from municipal wastewater influents in Japan. Appl Environ Microbiol 2019;85:e01661 -19.
[16] Abreo E, Altier N. Pangenome of Serratia marcescens strains from nosocomial and environmental origins reveals different populations and the links between them. Sci Rep 2019;9:46.
[17] Tanaka H, Hayashi W, Iimura M, Taniguchi Y, Soga E, Matsuo N, et al. Wastew- ater as a probable environmental reservoir of extended-spectrum-β-lactamase genes: detection of chimeric β-lactamases CTX-M-64 and CTX-M-123. Appl Environ Microbiol 2019;85:e01740 -19.
[18] Lartigue MF, Leflon-Guibout V, Poirel L, Nordmann P, Nicolas-Chanoine MH. Promoters P3, Pa/Pb, P4, and P5 upstream from blaTEM genes and their relation- ship to β-lactam resistance. Antimicrob Agents Chemother 2002;46:4035–7.
[19] Vinces MD, Legendre M, Caldara M, Hagihara M, Verstrepen KJ. Unsta- ble tandem repeats in promoters confer transcriptional evolvability. Science 2009;324:1213–16.
[20] König W, Faltin Y, Scheffer J, Schöffier H, Braun V. Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections. Infect Immun 1987;55:2554–61.